Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

451 public trials 58 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Prophylaxis of Hematologic Complications With Naderin in First-Line Breast Cancer Chemotherapy

NCT07671547

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
Locations: Not specified

View Trial Details

Completed

Secure Outsourcing of Carfilzomib in the Treatment of Multiple Myeloma to the Hospital at Home Setting

NCT05041933

Conditions: Hematologic Diseases, Hematological Diseases, Hemic and Lymphatic Diseases
Locations: Limoges Hospital Limoges, France

View Trial Details

Completed

The Impact of the Practice of Touch-massage on the Anxiety of Patients With Hematological Disorders Hospitalized in a Protective Environment, a Randomized, Controlled Study

NCT02343965

Conditions: Anxiety Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations: CHU de Nantes Nantes, France

View Trial Details

Completed

A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

NCT02158858

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Disease, +23 more
Locations: Mayo Clinic Arizona Phoenix, Arizona, United States

UCLA Medical Center Los Angeles, California, United States

Mayo Clinic Jacksonville Jacksonville, Florida, United States

Northwestern University - Lurie Comprehensive Cancer Center Chicago, Illinois, United States

View all 48 locations

View Trial Details

Completed

Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma

NCT05032820

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: City of Hope National Medical Center Duarte, California, United States

Stanford Hospital and Clinics Palo Alto, California, United States

University of California, San Francisco San Francisco, California, United States

H. Lee Moffitt Cancer Center Tampa, Florida, United States

View all 15 locations

View Trial Details

Completed

Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger

NCT06187831

Conditions: Bleeding, Blood Platelet Disorders, Central Line Complication, +7 more
Locations: Thomas Kander Lund, Lunds Universitet, Sweden

View Trial Details

Completed

Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response.

NCT03578367

Conditions: Bone Marrow Diseases, CML, Chronic Disease, +13 more
Locations: Georgia Regents University Augusta, Georgia, United States

Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

Novartis Investigative Site Vienna, Austria

Novartis Investigative Site Montreal, Quebec, Canada

View all 30 locations

View Trial Details

Completed

Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients

NCT03030248

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bone Marrow Transplant, +7 more
Locations: Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation

NCT04094844

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases
Locations: University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States

Oregon Health & Science University Portland, Oregon, United States

View Trial Details

Completed

Multimodal Sexual Dysfunction Intervention In HCT

NCT03803696

Conditions: Genital Diseases, Hematologic Diseases, Hematopoietic Stem Cell Transplantation, +4 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details